Adrenocortical Hyperfunction: Clinical Trials

5 trials for Adrenocortical Hyperfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 not yet recruiting. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Not yet recruiting 5

Follow Adrenocortical Hyperfunction: new trials by email Literature Review of Adrenocortical Hyperfunction trials Research Report on Adrenocortical Hyperfunction

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SYH2072 Tablets in Participants With Primary Aldosteronism
SYH2072 tablets, Placebo - Primary Aldosteronism
Phase 2Not yet recruitingInnovStone Therapeutics Limited602026-11-132026-11-06
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Osilodrostat (Isturisa), Placebo, hydrocortisone 10mg - Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Phase 2Not yet recruitingBeckey Trinh442026-11-012026-11-06
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism
SAL0140 Tablets, SAL0140 placebo - Primary Aldosteronism
Phase 2Not yet recruitingShenzhen Salubris Pharmaceuticals Co., Ltd.502026-06-122026-06-12
Study of QLS1410 in the Treatment of Primary Aldosteronism.
QLS1410, Placebo - Primary Aldosteronism
Phase 2Not yet recruitingQilu Pharmaceutical Co., Ltd.602026-06-012026-04-24
Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism
[68Ga]Ga-PentixaFor PET imaging - Primary Aldosteronism
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris202024-06-012024-06-27

Narrower conditions

Hyperaldosteronism (4)  ·  Cushing Syndrome (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Adrenal Gland Diseases (5)  ·  Endocrine System Diseases (5)  ·  Diabetes Mellitus (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Hydrocortisone (1)  ·  Osilodrostat (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Beckey Trinh (1)  ·  InnovStone Therapeutics Limited (1)  ·  Qilu Pharmaceutical Co., Ltd. (1)  ·  Shenzhen Salubris Pharmaceuticals Co., Ltd. (1)

Countries

China (2)  ·  France (1)  ·  Switzerland (1)

Top investigators

Beckey Trinh, PD, MD, PhD (1)  ·  Yuguo Chen, Medical Doctor (1)

NIH funding

2023 (1)